Spectral AI, Inc.
MDAI Healthcare Medical Devices
Spectral AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $19.7 million, down 33.6% from fiscal 2024. In the quarter to June 2026, revenue fell 30.4%, EPS grew 58.1%, free cash flow fell 21.9% and total debt rose 44.9%, each against the same quarter a year earlier.
Follow MDAI
Spectral AI, Inc. (MDAI) EV/Sales
As of 16 October 2026, Spectral AI, Inc. (MDAI) trades at a EV/Sales of 3.0×. Over the past ten years it has ranged from 0.0× (June 2023) to 5.5× (September 2023); the current reading is higher than 88% of that period. That is above the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.4× | (10.18%) |
| FY2024 | 1.6× | (8.49%) |
| FY2023 | 1.7× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 3.4× | 46.32% |
| Mar 2026 | 2.3× | 64.99% |
| Dec 2025 | 1.4× | (41.57%) |
| Sep 2025 | 2.4× | 10.89% |
| 12 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| TLIS Talis Biomedical Corporation compare | −55.3× |
| XTNT Xtant Medical Holdings, Inc. compare | 0.5× |
| RPID Rapid Micro Biosystems, Inc. compare | 1.0× |
| TELA TELA Bio, Inc. compare | 1.1× |
| MYO Myomo, Inc. compare | 1.2× |
| SNWV Sanuwave Health Inc. compare | 1.2× |
| SRTS Sensus Healthcare, Inc. compare | 2.1× |
| MDAI Spectral AI, Inc. | 3.0× |
| COCH Envoy Medical, Inc. compare | 390× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)